Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 332

1.

Role of the human ST6GalNAc-I and ST6GalNAc-II in the synthesis of the cancer-associated sialyl-Tn antigen.

Marcos NT, Pinho S, Grandela C, Cruz A, Samyn-Petit B, Harduin-Lepers A, Almeida R, Silva F, Morais V, Costa J, Kihlberg J, Clausen H, Reis CA.

Cancer Res. 2004 Oct 1;64(19):7050-7.

2.

Redefined substrate specificity of ST6GalNAc II: a second candidate sialyl-Tn synthase.

Kono M, Tsuda T, Ogata S, Takashima S, Liu H, Hamamoto T, Itzkowitz SH, Nishimura S, Tsuji S.

Biochem Biophys Res Commun. 2000 May 27;272(1):94-7.

PMID:
10872809
3.

Cloning and expression of a human gene encoding an N-acetylgalactosamine-alpha2,6-sialyltransferase (ST6GalNAc I): a candidate for synthesis of cancer-associated sialyl-Tn antigens.

Ikehara Y, Kojima N, Kurosawa N, Kudo T, Kono M, Nishihara S, Issiki S, Morozumi K, Itzkowitz S, Tsuda T, Nishimura SI, Tsuji S, Narimatsu H.

Glycobiology. 1999 Nov;9(11):1213-24.

PMID:
10536037
4.

The ST6GalNAc-I sialyltransferase localizes throughout the Golgi and is responsible for the synthesis of the tumor-associated sialyl-Tn O-glycan in human breast cancer.

Sewell R, Bäckström M, Dalziel M, Gschmeissner S, Karlsson H, Noll T, Gätgens J, Clausen H, Hansson GC, Burchell J, Taylor-Papadimitriou J.

J Biol Chem. 2006 Feb 10;281(6):3586-94. Epub 2005 Nov 30.

5.

Expression of sialyl-Tn antigen in breast cancer cells transfected with the human CMP-Neu5Ac: GalNAc alpha2,6-sialyltransferase (ST6GalNac I) cDNA.

Julien S, Krzewinski-Recchi MA, Harduin-Lepers A, Gouyer V, Huet G, Le Bourhis X, Delannoy P.

Glycoconj J. 2001 Nov-Dec;18(11-12):883-93.

PMID:
12820722
6.

Stable expression of sialyl-Tn antigen in T47-D cells induces a decrease of cell adhesion and an increase of cell migration.

Julien S, Lagadec C, Krzewinski-Recchi MA, Courtand G, Le Bourhis X, Delannoy P.

Breast Cancer Res Treat. 2005 Mar;90(1):77-84.

PMID:
15770530
7.

Overexpression of sialyltransferase CMP-sialic acid:Galbeta1,3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas.

Schneider F, Kemmner W, Haensch W, Franke G, Gretschel S, Karsten U, Schlag PM.

Cancer Res. 2001 Jun 1;61(11):4605-11.

8.

Efficient chemoenzymatic synthesis of O-linked sialyl oligosaccharides.

Blixt O, Allin K, Pereira L, Datta A, Paulson JC.

J Am Chem Soc. 2002 May 22;124(20):5739-46.

PMID:
12010048
9.

ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity.

Julien S, Adriaenssens E, Ottenberg K, Furlan A, Courtand G, Vercoutter-Edouart AS, Hanisch FG, Delannoy P, Le Bourhis X.

Glycobiology. 2006 Jan;16(1):54-64. Epub 2005 Aug 31.

PMID:
16135558
10.

Chemoenzymatic synthesis of sialylated glycopeptides derived from mucins and T-cell stimulating peptides.

George SK, Schwientek T, Holm B, Reis CA, Clausen H, Kihlberg J.

J Am Chem Soc. 2001 Nov 14;123(45):11117-25.

PMID:
11697954
11.

ST6GalNAc-I controls expression of sialyl-Tn antigen in gastrointestinal tissues.

Marcos NT, Bennett EP, Gomes J, Magalhaes A, Gomes C, David L, Dar I, Jeanneau C, DeFrees S, Krustrup D, Vogel LK, Kure EH, Burchell J, Taylor-Papadimitriou J, Clausen H, Mandel U, Reis CA.

Front Biosci (Elite Ed). 2011 Jun 1;3:1443-55.

PMID:
21622148
12.
13.

Molecular basis of incomplete O-glycan synthesis in MCF-7 breast cancer cells: putative role of MUC6 in Tn antigen expression.

Freire T, Bay S, von Mensdorff-Pouilly S, Osinaga E.

Cancer Res. 2005 Sep 1;65(17):7880-7.

14.

Cloning, expression and gene organization of a human Neu5Ac alpha 2-3Gal beta 1-3GalNAc alpha 2,6-sialyltransferase: hST6GalNAcIV.

Harduin-Lepers A, Stokes DC, Steelant WF, Samyn-Petit B, Krzewinski-Recchi MA, Vallejo-Ruiz V, Zanetta JP, Augé C, Delannoy P.

Biochem J. 2000 Nov 15;352 Pt 1:37-48.

15.

Synthesis of disialyl Lewis a (Le(a)) structure in colon cancer cell lines by a sialyltransferase, ST6GalNAc VI, responsible for the synthesis of alpha-series gangliosides.

Tsuchida A, Okajima T, Furukawa K, Ando T, Ishida H, Yoshida A, Nakamura Y, Kannagi R, Kiso M, Furukawa K.

J Biol Chem. 2003 Jun 20;278(25):22787-94. Epub 2003 Mar 31.

16.

Molecular characterization of pig alpha2,3-Gal-beta1,3-GalNAc-alpha2,6-sialyltransferase (pST6GalNAc IV) gene specific for Neu5Acalpha2-3Galbeta1-3GalNAc trisaccharide structure.

Ko HK, Song KH, Jin UH, Seong HH, Chang YC, Kim NH, Kim DS, Lee YC, Kim CH.

Glycoconj J. 2010 Apr;27(3):367-74. doi: 10.1007/s10719-010-9284-3. Epub 2010 Mar 22.

PMID:
20306343
19.

Molecular cloning of a developmentally regulated N-acetylgalactosamine alpha2,6-sialyltransferase specific for sialylated glycoconjugates.

Sjoberg ER, Kitagawa H, Glushka J, van Halbeek H, Paulson JC.

J Biol Chem. 1996 Mar 29;271(13):7450-9.

20.

Differential expression of alpha-2,3-sialyltransferases and alpha-1,3/4-fucosyltransferases regulates the levels of sialyl Lewis a and sialyl Lewis x in gastrointestinal carcinoma cells.

Carvalho AS, Harduin-Lepers A, Magalhães A, Machado E, Mendes N, Costa LT, Matthiesen R, Almeida R, Costa J, Reis CA.

Int J Biochem Cell Biol. 2010 Jan;42(1):80-9. doi: 10.1016/j.biocel.2009.09.010. Epub 2009 Sep 23.

PMID:
19781661

Supplemental Content

Support Center